X T L Biopharmaceuticals reported $166K in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Bioline Rx USD 21.58M 2.1M Mar/2026
Teva Pharmaceutical Industries USD 13.76B 50M Jun/2026
X T L Biopharmaceuticals USD 166K 367K Dec/2025